Novartis AG 0K9E-GB:London Stock Exchange
RT Quote | Exchange | USD
Last | 05/16/24 BST
0.00UNCH (UNCH)
52 week range
89.00 - 111.82
- Open0.00
- Day High0.00
- Day Low0.00
- Prev Close0.00
- 52 Week High111.82
- 52 Week High Date01/11/24
- 52 Week Low89.00
- 52 Week Low Date07/07/23
Key Stats
- Market Cap199,362.48M
- Shares Out1,956.49M
- 10 Day Average Volume5,611.67
- Dividend3.74
- Dividend Yield-
- Beta-
- YTD % Change1.77
KEY STATS
- Open0.00
- Day High0.00
- Day Low0.00
- Prev Close0.00
- 52 Week High111.82
- 52 Week High Date01/11/24
- 52 Week Low89.00
- 52 Week Low Date07/07/23
- Market Cap199,362.48M
- Shares Out1,956.49M
- 10 Day Average Volume5,611.67
- Dividend3.74
- Dividend Yield-
- Beta-
- YTD % Change1.77
RATIOS/PROFITABILITY
- EPS (TTM)4.41
- P/E (TTM)-
- Fwd P/E (NTM)-
- EBITDA (TTM)-
- ROE (TTM)-
- Revenue (TTM)-
- Gross Margin (TTM)-
- Net Margin (TTM)-
- Debt To Equity (MRQ)-
EVENTS
- Earnings Date-
- Ex Div Date03/07/2024
- Div Amount3.7395
- Split Date-
- Split Factor-
Latest On Novartis AG
Content From Our Affiliates
Related Video
Profile
MORENovartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided...
Joerg Reinhardt Ph.D.
Independent Non-Executive Chairman of the Board
Vasant Narasimhan M.D.
Chief Executive Officer, Member of the Executive Committee
Harry Kirsch
Chief Financial Officer, Member of the Executive Committee
Address
Lichtstrasse 35
Basel
4056
Switzerland